These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 36367873)
21. Mother-to-infant transmission of the carcinogenic colibactin-producing bacteria. Tsunematsu Y; Hosomi K; Kunisawa J; Sato M; Shibuya N; Saito E; Murakami H; Yoshikawa Y; Iwashita Y; Miyoshi N; Mutoh M; Ishikawa H; Sugimura H; Miyachi M; Wakabayashi K; Watanabe K BMC Microbiol; 2021 Aug; 21(1):235. PubMed ID: 34429063 [TBL] [Abstract][Full Text] [Related]
22. Targeting colorectal cancer-associated bacteria: A new area of research for personalized treatments. Faïs T; Delmas J; Cougnoux A; Dalmasso G; Bonnet R Gut Microbes; 2016 Jul; 7(4):329-333. PubMed ID: 27007710 [TBL] [Abstract][Full Text] [Related]
31. Colonization of the gut mucosa of colorectal cancer patients by pathogenic mucosa-associated Escherichia coli strains. Nouri R; Hasani A; Shirazi KM; Sefiadn FY; Mazraeh FN; Sattarpour S; Rezaee MA Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116229. PubMed ID: 38507962 [TBL] [Abstract][Full Text] [Related]
32. Colibactin: More Than a New Bacterial Toxin. Faïs T; Delmas J; Barnich N; Bonnet R; Dalmasso G Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29642622 [TBL] [Abstract][Full Text] [Related]
33. The Polyamine Spermidine Modulates the Production of the Bacterial Genotoxin Colibactin. Chagneau CV; Garcie C; Bossuet-Greif N; Tronnet S; Brachmann AO; Piel J; Nougayrède JP; Martin P; Oswald E mSphere; 2019 Oct; 4(5):. PubMed ID: 31578245 [TBL] [Abstract][Full Text] [Related]
34. Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients. Miyasaka T; Yamada T; Uehara K; Sonoda H; Matsuda A; Shinji S; Ohta R; Kuriyama S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kanaka S; Ohashi R; Yoshida H Cancer Sci; 2024 Apr; 115(4):1184-1195. PubMed ID: 38297479 [TBL] [Abstract][Full Text] [Related]
35. Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet? Tang-Fichaux M; Branchu P; Nougayrède JP; Oswald E Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941734 [TBL] [Abstract][Full Text] [Related]
36. Molecular Genetic and Functional Analysis of Suresh A; Ranjan A; Jadhav S; Hussain A; Shaik S; Alam M; Baddam R; Wieler LH; Ahmed N Front Microbiol; 2018; 9():2631. PubMed ID: 30498477 [TBL] [Abstract][Full Text] [Related]
37. Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells. Sogari A; Rovera E; Grasso G; Mariella E; Reilly NM; Lamba S; Mauri G; Durinikova E; Vitiello PP; Lorenzato A; Avolio M; Piumatti E; Bonoldi E; Aquilano MC; Arena S; Sartore-Bianchi A; Siena S; Trusolino L; Donalisio M; Russo M; Di Nicolantonio F; Lembo D; Bardelli A Cell Rep Med; 2024 Feb; 5(2):101376. PubMed ID: 38228147 [TBL] [Abstract][Full Text] [Related]
39. Advancing the Biosynthetic and Chemical Understanding of the Carcinogenic Risk Factor Colibactin and Its Producers. Hirayama Y; Sato M; Watanabe K Biochemistry; 2022 Dec; 61(24):2782-2790. PubMed ID: 35723977 [TBL] [Abstract][Full Text] [Related]
40. Two Polyketides Intertwined in Complex Regulation: Posttranscriptional CsrA-Mediated Control of Colibactin and Yersiniabactin Synthesis in Escherichia coli. Rehm N; Wallenstein A; Keizers M; Homburg S; Magistro G; Chagneau CV; Klimek H; Revelles O; Helloin E; Putze J; Nougayrède JP; Schubert S; Oswald E; Dobrindt U mBio; 2021 Feb; 13(1):e0381421. PubMed ID: 35100864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]